Sartorius Stedim Biotech SA (DIM), with a market capitalization of $135.93 million, reported robust earnings for the first quarter of 2025, exceeding analyst expectations with an earnings per share ...

Sartorius Stedim Biotech SA (DIM), with a market capitalization of $135.93 million, reported robust earnings for the first quarter of 2025, exceeding analyst expectations with an earnings per ...

The shares of Sartorius Stedim Biotech S.A. are quoted on the Euronext Paris. The company has a strong global reach with manufacturing and R&D sites as well as sales entities in Europe, North America, ...

In a challenging environment, Sartorius Stedim Biotech, a leading provider of innovative technologies for the manufacture of biologics, closed the fiscal year with a solid performance. With sales ...

Jan 28 (Reuters) - Shares in Sartorius (SATG.DE), opens new tab jumped 15.6% on Tuesday after the Franco-German lab supplies maker's preliminary annual results beat expectations and despite a ...

Sartorius Stedim Biotech, a leading partner of the biopharmaceutical industry, opened its new Center for Bioprocess Innovation in Marlborough, Massachusetts. This state-of-the-art facility is designed ...

Sartorius Stedim Biotech opened its new centre for Bioprocess Innovation in Marlborough French biopharmaceutical company Sartorius Stedim Biotech has announced the opening of its new centre for ...

Sartorius Stedim Biotech, the bioprocess subsidiary of Sartorius AG, is a leading provider of single-use biopharmaceutical fermentation and fluid management solutions. Sartorius performs ...

DJ Sartorius Stedim Biotech Capital Markets: Links to presentation and webcast Sartorius Stedim Biotech SA / Key word(s): Miscellaneous Sartorius Stedim Biotech Capital Markets: Links to ...

Ladies and gentlemen, welcome to the Sartorius and Sartorius Stedim Biotech conference call and live webcast on the preliminary full year 2023 results. I'm Sascha, the Chorus Call operator.